BioNTech Ends Personalized mRNA Cancer Vaccine Trial After Colorectal Cancer Study Fails to Show Benefit
Mainz, Germany, August 29, 2026: BioNTech has stopped a mid-stage clinical trial testing its personalized mRNA cancer immunotherapy in patients...